MannKind Corp
MNKD
#5898
Rank
A$1.75 B
Marketcap
A$5.46
Share price
-3.80%
Change (1 day)
-34.28%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): A-$0.19

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is A-$0.19. In 2025 the company made an earnings per share (EPS) of A$0.02875 a decrease over its 2024 EPS that were of A$0.14.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.19-755.08%
2025A$0.02875-80%
2024A$0.14
2022A-$0.496.25%
2021A-$0.4628%
2020A-$0.36-7.41%
2019A-$0.39
2017A-$1.60-188.1%
2016A$1.81-128.31%
2015A-$6.4074.51%
2014A-$3.67-20.31%
2013A-$4.60-32.63%
2012A-$6.83-28.03%
2011A-$9.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.09-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$5.86-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$42.95-23,087.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.82-1,073.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$5.06-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$9.63 5,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA